Commit Biologics
PrivateLast Round
Seed
Jan 28, 2025
Total Funding Raised
$22.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Commit Biologics is a biotechnology company that develops a novel immunotherapy platform, BiCE™, to treat cancer and autoimmune diseases by activating the complement system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Commit Biologics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Commit Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 28, 2025 | ||||
| Seed | May 9, 2024 |
Commit Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korys | Seed |
| Novo Holdings | Seed |
| Bioqube Ventures | Seed |
| BioInnovation Institute | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2026
Intention to advance complement-powered immune engagers into clinical trials.
- Mar 16, 2026
Thomas Montgomery Andresen appointed as new Chief Executive Officer.
Commit Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Commit Biologics's valuation, stock price, and market status.